J Korean Neurol Assoc.  2016 Aug;34(3):224-227. 10.17340/jkna.2016.34.3.11.

Cap Myopathy With a Heterozygous TPM3 Missense Mutation

Affiliations
  • 1Department of Neurology, Pusan National University School of Medicine, Busan, Korea. yepark407@gmail.com
  • 2Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
  • 3Department of Pathology, Pusan National University School of Medicine, Busan, Korea.

Abstract

Cap myopathy is pathologically characterized by cap structures comprising well-demarcated areas under the sarcolemma and containing deranged myofibrils and scattered Z-disks. Clinically it presents with slowly progressive muscle weakness, myopathic face, and frequent respiratory insufficiency. Four genes have been reported to be associated with the disease: TPM2, TPM3, ACTA1, and NEB. Here we describe that a patient presenting with mild limb weakness with facial affection showed cap structures on muscle pathology and carried a heterozygous TPM3 mutation.

Keyword

Cap myopathy; Tropomyosin; TPM3

MeSH Terms

Extremities
Humans
Muscle Weakness
Muscular Diseases*
Mutation, Missense*
Myofibrils
Pathology
Respiratory Insufficiency
Sarcolemma
Tropomyosin
Tropomyosin
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr